← Back to Search

A4i Intervention for Schizophrenia

N/A

Waitlist Available

Research Sponsored by Centre for Addiction and Mental Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 27 months.

Awards & highlights

Study Summary

This trial will test the feasibility of a new digital health technology called App4Independence to help address some of the challenges in treating schizophrenia.

Eligible Conditions

Schizophrenia
Psychosis
Schizoaffective Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 27 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~27 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of Treatment-Emergent Adverse Events

Objective App Use

Recruitment

+1 more

Secondary outcome measures

App Strengths and Limitations

Appointment Attendence

Clinical Alliance

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: A4i InterventionExperimental Treatment1 Intervention

App4Independence (A4i) Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data. Specific A4i functionality includes: Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources. Fostering illness self-management through evidence-informed content. A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated). Daily wellness and goal attainment check-ins. An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds. Passively collected data on phone use as a proxy for sleep. A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU).

Group II: Treatment As UsualActive Control1 Intervention

Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

A4i Intervention

2021

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor

356 Previous Clinical Trials

81,368 Total Patients Enrolled

58 Trials studying Schizophrenia

4,141 Patients Enrolled for Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for enrolment in this investigation?

"Affirmative, the clinicaltrials.gov website indicates that this experiment is actively recruiting patients. It was initially posted on April 1st 2021 and modified most recently on May 2nd 2021. The research team are currently looking for 160 volunteers from one site."

Answered by AI

Is enrollment to this trial still available for participants?

"Indeed, the latest information available on clinicaltrials.gov states that this experiment is actively recruiting participants. It was posted in early January 2021 and has since been updated once more in February of the same year. 160 volunteers are needed at a single medical centre to participate in this study."

Answered by AI

How does this experiment hope to reach its goals?

"This clinical trial will last for 27 months, and its primary aim is to measure Objective App Use. Assessing secondary outcomes such as Psychiatric Symptoms (using the Brief Symptom Inventory), Clinical Alliance (via the Scale to Assess the Therapeutic Relationship) and App Strengths and Limitations requires a Research Assistant contacting treatment arm providers/participants for semi-structured interviews."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Sean Kidd 2021. "Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04602741.